These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24989489)

  • 21. Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program.
    Khan NA; Herman RJ; Quinn RR; Rabkin SW; Ravani P; Tobe SW; Feldman RD; Wijeysundera HC; Padwal RS;
    Can J Cardiol; 2014 Jan; 30(1):16-21. PubMed ID: 24269056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catheter-based renal denervation for treatment of resistant hypertension.
    Vase H; Mathiassen ON; Kaltoft A; Pedersen EB; Christensen KL; Buus NH; Lederballe O; Lassen JF; Bøtker HE; Thuesen L
    Dan Med J; 2012 Jun; 59(6):A4439. PubMed ID: 22677237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reply: A mechanistic explanation for the minimal impact of renal denervation on 24-h ambulatory blood pressure in SIMPLICITY HTN-3.
    Bakris GL; Bhatt DL
    J Am Coll Cardiol; 2015 Mar; 65(9):959-60. PubMed ID: 25744018
    [No Abstract]   [Full Text] [Related]  

  • 24. Renal denervation: Should we ignore the proximal segment of renal artery?
    Huang B; Zhou X; Jiang H
    Int J Cardiol; 2017 Dec; 249():364. PubMed ID: 29121740
    [No Abstract]   [Full Text] [Related]  

  • 25. Renal Denervation for Treatment of Hypertension: a Second Start and New Challenges.
    Persu A; Kjeldsen S; Staessen JA; Azizi M
    Curr Hypertens Rep; 2016 Jan; 18(1):6. PubMed ID: 26739586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catheter-based renal denervation for resistant hypertension: 12-month results of the EnligHTN I first-in-human study using a multielectrode ablation system.
    Papademetriou V; Tsioufis CP; Sinhal A; Chew DP; Meredith IT; Malaiapan Y; Worthley MI; Worthley SG
    Hypertension; 2014 Sep; 64(3):565-72. PubMed ID: 24935940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrospective morphometric study of the suitability of renal arteries for renal denervation according to the Symplicity HTN2 trial criteria.
    Schönherr E; Rehwald R; Nasseri P; Luger AK; Grams AE; Kerschbaum J; Rehder P; Petersen J; Glodny B
    BMJ Open; 2016 Jan; 6(1):e009351. PubMed ID: 26729385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal denervation for uncontrolled hypertension: critical review of the evidence.
    Chen C; Upadhyay A
    Curr Opin Nephrol Hypertens; 2017 Mar; 26(2):114-122. PubMed ID: 27922849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Symplicity multi-electrode radiofrequency renal denervation system feasibility study.
    Whitbourn R; Harding SA; Walton A
    EuroIntervention; 2015 May; 11(1):104-9. PubMed ID: 25982652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Renal denervation a treatment for resistant hypertension: a French experience].
    Benamer H; Mylotte D; Garcia-Alonso C; Unterseeh T; Garot P; Louvard Y; Lefevre T; Morice MC;
    Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):384-91. PubMed ID: 24182849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal denervation for resistant hypertension: not dead yet.
    Reddy VY; Olin JW
    J Am Coll Cardiol; 2014 Sep; 64(11):1088-91. PubMed ID: 25212641
    [No Abstract]   [Full Text] [Related]  

  • 32. First-in-man radial access renal denervation with the ReCor Radiance™ catheter.
    Daemen J; Van Mieghem N
    EuroIntervention; 2015 Feb; 10(10):1209-12. PubMed ID: 25493912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry.
    Mahfoud F; Bakris G; Bhatt DL; Esler M; Ewen S; Fahy M; Kandzari D; Kario K; Mancia G; Weber M; Böhm M
    Eur Heart J; 2017 Jan; 38(2):93-100. PubMed ID: 28158510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.
    ; Esler MD; Krum H; Sobotka PA; Schlaich MP; Schmieder RE; Böhm M
    Lancet; 2010 Dec; 376(9756):1903-9. PubMed ID: 21093036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of renal sympathetic denervation on cardiac sympathetic activity and function in patients with therapy resistant hypertension.
    van Brussel PM; Eeftinck Schattenkerk DW; Dobrowolski LC; de Winter RJ; Reekers JA; Verberne HJ; Vogt L; van den Born BJ
    Int J Cardiol; 2016 Jan; 202():609-14. PubMed ID: 26447672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catheter-based renal denervation in hypertension: heading for new shores.
    Mahfoud F; Böhm M; Edelman ER
    J Hypertens; 2018 Jan; 36(1):41-42. PubMed ID: 29210859
    [No Abstract]   [Full Text] [Related]  

  • 37. A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs.
    Mauri L; Kario K; Basile J; Daemen J; Davies J; Kirtane AJ; Mahfoud F; Schmieder RE; Weber M; Nanto S; Azizi M
    Am Heart J; 2018 Jan; 195():115-129. PubMed ID: 29224639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings.
    Esler M
    J Am Soc Hypertens; 2014 Aug; 8(8):593-8. PubMed ID: 25151320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mid-Term Vascular Safety of Renal Denervation Assessed by Follow-up MR Imaging.
    Schmid A; Schmieder R; Lell M; Janka R; Veelken R; Schmieder RE; Uder M; Ott C
    Cardiovasc Intervent Radiol; 2016 Mar; 39(3):426-32. PubMed ID: 26253780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal denervation and hypertension resistant drug treatment in patient with renal artery accessory.
    Imbalzano E; Ceravolo R; Vatrano M; Lizio G; Saitta A
    Int J Cardiol; 2014 Jan; 171(1):e8-9. PubMed ID: 24331865
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.